trending Market Intelligence /marketintelligence/en/news-insights/trending/hD_SvfepaGueGfH5wB_Rrw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

US FDA approves 2 Teva Pharmaceutical asthma inhalers

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


US FDA approves 2 Teva Pharmaceutical asthma inhalers

The U.S. FDA approved two Teva Pharmaceutical Industries Ltd. asthma inhalers.

The inhalers, AirDuo RespiClick and ArmonAir RespiClick, will be available for adolescent and adult patients via prescription later this year.